Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about INSULIN SIGNALING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
INSULIN SIGNALING is a concept in neurodegeneration research. Key relationships include: transports, co discussed, causes. Associated with NEURODEGENERATION. Connected to 14 entities in the SciDEX knowledge graph.
| Name | INSULIN SIGNALING |
| Summary | # [Brain Insulin Signaling](/entities/brain-insulin-signaling) ## Introduction [Brain Insulin Signaling](/entities/brain-insulin-signaling) is an important component in the neurobiology of neurodegen |
| Key Genes/Proteins | TNF, APP, GLUT4, MAPT |
| Related Diseases | ALZHEIMER'S DISEASE, INSULIN RESISTANCE, NEURODEGENERATION |
Knowledge base pages for this entity
graph TD
INSULIN_SIGNALING["INSULIN SIGNALING"]
INSULIN_SIGNALING -->|"interacts"| Cholesterol["Cholesterol"]
INSULIN_SIGNALING -->|"interacts"| Glycolysis["Glycolysis"]
INSULIN_SIGNALING -->|"interacts"| Mtor["Mtor"]
INSULIN_SIGNALING -->|"interacts"| Synaptic_Plasticity["Synaptic Plasticity"]
INSULIN_SIGNALING -->|"interacts"| Nf__b["Nf-Kappab"]
IRS1["IRS1"] -->|"regulates"| INSULIN_SIGNALING
PI3K_Akt_mTOR["PI3K-Akt-mTOR"] -->|"interacts"| INSULIN_SIGNALING
PI3K_Akt_mTOR_pathway["PI3K-Akt/mTOR pathway"] -->|"interacts"| INSULIN_SIGNALING
IGF_1["IGF-1"] -->|"regulates"| INSULIN_SIGNALING
JUN["JUN"] -->|"activates"| INSULIN_SIGNALING
MTOR["MTOR"] -->|"activates"| INSULIN_SIGNALING
AKT["AKT"] -->|"activates"| INSULIN_SIGNALING
GENES["GENES"] -->|"activates"| INSULIN_SIGNALING
Obesity["Obesity"] -->|"activates"| INSULIN_SIGNALING
Diabetes["Diabetes"] -->|"activates"| INSULIN_SIGNALING| Target | Relation | Type | Str |
|---|---|---|---|
| Insulin Resistance | involved_in | phenotype | 0.90 |
| Alzheimer's Disease | involved_in | disease | 0.90 |
| Parkinson's Disease | involved_in | disease | 0.90 |
| Cognitive Function | regulates | phenotype | 0.90 |
| Mitochondrial Dysfunction | regulates | process | 0.90 |
| Glucose Disposal | regulates | phenotype | 0.90 |
| NEURODEGENERATION | protects_against | process | 0.88 |
| TAU | regulates | protein | 0.85 |
| MTOR | upstream_of | gene | 0.80 |
| Insulin Resistance | causes | phenotype | 0.80 |
| Tau Hyperphosphorylation | inhibits | process | 0.80 |
| Autophagy | regulates | process | 0.80 |
| neurons | active_in | cell_type | 0.80 |
| Retinal Ganglion Cell Neuroprotection | involved_in | mechanism | 0.80 |
| neural stem cells | active_in | cell_type | 0.80 |
| Retinal Ganglion Cell | modulates | cell_type | 0.75 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| astrocytes | active_in | cell_type | 0.70 |
| TNF | activates | gene | 0.70 |
| blood-brain barrier | active_in | brain_region | 0.70 |
| ALZHEIMER'S DISEASE | treats | disease | 0.65 |
| NEURONS | activates | cell_type | 0.65 |
| APP | regulates | gene | 0.65 |
| INSULIN RESISTANCE | treats | phenotype | 0.65 |
| synaptic plasticity | crosstalk_with | pathway | 0.60 |
| hippocampus | active_in | brain_region | 0.60 |
| endothelial cells | active_in | cell_type | 0.60 |
| cortex | active_in | brain_region | 0.60 |
| unfolded protein response | crosstalk_with | pathway | 0.60 |
| Cholesterol | interacts_with | pathway | 0.55 |
| Glycolysis | interacts_with | pathway | 0.55 |
| Mtor | interacts_with | pathway | 0.55 |
| Synaptic Plasticity | interacts_with | pathway | 0.55 |
| Nf-Κb | interacts_with | pathway | 0.55 |
| MTOR | co_discussed | entity | 0.50 |
| INSULIN | activates | concept | 0.50 |
| RAPAMYCIN | activates | concept | 0.50 |
| INSULIN | associated_with | concept | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| AXON | protects_against | concept | 0.50 |
| INSULIN | protects_against | concept | 0.50 |
| Neuroprotection | protects_against | process | 0.50 |
| Pi3K/Akt | activates | pathway | 0.50 |
| disease | activates | disease | 0.50 |
| PI3K/AKT/mTOR | activates | pathway | 0.50 |
| Pi3K/Akt | inhibits | pathway | 0.50 |
| INSULIN | inhibits | concept | 0.50 |
| PI3K/AKT/mTOR | inhibits | pathway | 0.50 |
| disease | regulates | disease | 0.50 |
| ALZHEIMER'S | regulates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| PI3K | activates | gene | 1.00 |
| INSULIN RESISTANCE | activates | gene | 1.00 |
| Aging | activates | disease | 1.00 |
| Insulin Resistance | activates | disease | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| AKT | mediates | protein | 0.95 |
| GLP-1 | associated_with | protein | 0.95 |
| GLP-1 | promotes | protein | 0.95 |
| insulin receptor | activates | receptor | 0.90 |
| AKT | component_of | protein | 0.90 |
| MTOR | component_of | protein | 0.90 |
| GLP-1R | activates | receptor | 0.90 |
| AMPK | regulates | protein | 0.90 |
| diabetes | involves | disease | 0.90 |
| Alzheimer's disease | involves | disease | 0.90 |
| MTOR | activates | gene | 0.90 |
| AKT | activates | gene | 0.90 |
| GENES | activates | gene | 0.90 |
| Alzheimer | activates | disease | 0.90 |
| Aging | therapeutic_target | disease | 0.90 |
| AGING | activates | gene | 0.90 |
| Glp-1 Receptor Agonists | associated_with | drug | 0.87 |
| resveratrol | activates | drug | 0.85 |
| APOE4 | participates_in | gene | 0.85 |
| astrocytes | active_in | cell_type | 0.85 |
| microglia | active_in | cell_type | 0.85 |
| neurons | active_in | cell_type | 0.85 |
| PI3K | participates_in | gene | 0.80 |
| neurodegeneration | involves | disease | 0.80 |
| MTOR | inhibits | gene | 0.80 |
| Obesity | activates | disease | 0.80 |
| Diabetes | activates | disease | 0.80 |
| Diabetes | contributes_to | disease | 0.80 |
| Neurodegeneration | contributes_to | disease | 0.80 |
| Cardiovascular | activates | disease | 0.80 |
| Diabetes | therapeutic_target | disease | 0.80 |
| INSULIN RESISTANCE | therapeutic_target | gene | 0.80 |
| OXIDATIVE STRESS | contributes_to | gene | 0.80 |
| AKT | regulates | gene | 0.80 |
| NEURODEGENERATION | contributes_to | gene | 0.80 |
| INSULIN RESISTANCE | contributes_to | gene | 0.80 |
| Insulin Resistance | contributes_to | disease | 0.80 |
| TAU | activates | gene | 0.80 |
| APOPTOSIS | activates | gene | 0.80 |
| ALZHEIMER | activates | gene | 0.80 |
| ALZHEIMER'S DISEASE | activates | gene | 0.80 |
| ALZHEIMER | associated_with | gene | 0.80 |
| AMYLOID | activates | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||